233 related articles for article (PubMed ID: 17917540)
21. Classification in systemic sclerosis.
Johnson SR; Laxer RM
J Rheumatol; 2006 May; 33(5):840-1. PubMed ID: 16652415
[No Abstract] [Full Text] [Related]
22. Criteria for the classification of early systemic sclerosis.
LeRoy EC; Medsger TA
J Rheumatol; 2001 Jul; 28(7):1573-6. PubMed ID: 11469464
[TBL] [Abstract][Full Text] [Related]
23. Molecular pathways as novel therapeutic targets in systemic sclerosis.
Trojanowska M; Varga J
Curr Opin Rheumatol; 2007 Nov; 19(6):568-73. PubMed ID: 17917537
[TBL] [Abstract][Full Text] [Related]
24. [Systemic sclerosis: different subsets and disease remitting drugs].
Ogawa T; Saito E
Nihon Rinsho; 1999 Feb; 57(2):344-8. PubMed ID: 10078002
[TBL] [Abstract][Full Text] [Related]
25. Factors affecting survival in juvenile systemic sclerosis.
Martini G; Vittadello F; Kasapçopur O; Magni Manzoni S; Corona F; Duarte-Salazar C; Nemcova D; Len CA; Garay SM; Ullman S; Zulian F;
Rheumatology (Oxford); 2009 Feb; 48(2):119-22. PubMed ID: 18854345
[TBL] [Abstract][Full Text] [Related]
26. Scleroderma in children: emerging management issues.
Panda S
Indian J Dermatol Venereol Leprol; 2010; 76(4):348-56. PubMed ID: 20657114
[TBL] [Abstract][Full Text] [Related]
27. Network in pediatric rheumatology: the example of pediatric rheumatology international trials organisation.
Ruperto N; Martini A
Georgian Med News; 2008 Mar; (156):68-74. PubMed ID: 18403813
[TBL] [Abstract][Full Text] [Related]
28. Systemic sclerosis/scleroderma: a treatable multisystem disease.
Hinchcliff M; Varga J
Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis, management and prevention of scleroderma renal disease.
Penn H; Denton CP
Curr Opin Rheumatol; 2008 Nov; 20(6):692-6. PubMed ID: 18946330
[TBL] [Abstract][Full Text] [Related]
30. [Systemic sclerosis. A diagnostic and follow-up program].
Rødevand E; Skomsvoll JF; Ostensen M
Tidsskr Nor Laegeforen; 1997 Sep; 117(22):3221-3. PubMed ID: 9411861
[TBL] [Abstract][Full Text] [Related]
31. Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry.
Avcin T; Cimaz R; Silverman ED; Cervera R; Gattorno M; Garay S; Berkun Y; Sztajnbok FR; Silva CA; Campos LM; Saad-Magalhaes C; Rigante D; Ravelli A; Martini A; Rozman B; Meroni PL
Pediatrics; 2008 Nov; 122(5):e1100-7. PubMed ID: 18955411
[TBL] [Abstract][Full Text] [Related]
32. Functional outcome in a patient with an acute quadriparesis secondary to systemic sclerosis: a case report.
Chernev I; Gustafson K; Medina-Bravo A
Arch Phys Med Rehabil; 2009 Jan; 90(1):170-2. PubMed ID: 19154843
[TBL] [Abstract][Full Text] [Related]
33. [Some aspects of systemic and localized (limited) sclerosis in children].
Kwiatkowska M; Rutkowska-Sak L; Zuber Z
Ann Acad Med Stetin; 2012; 58(1):23-7. PubMed ID: 23547390
[TBL] [Abstract][Full Text] [Related]
34. Systemic sclerosis-scleroderma.
Haustein UF
Dermatol Online J; 2002 Jun; 8(1):3. PubMed ID: 12165213
[TBL] [Abstract][Full Text] [Related]
35. Revising the classification criteria for systemic sclerosis.
Nadashkevich O; Davis P; Fritzler MJ
Arthritis Rheum; 2006 Dec; 55(6):992-3. PubMed ID: 17139623
[No Abstract] [Full Text] [Related]
36. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy.
Matucci-Cerinic M; Allanore Y; Czirják L; Tyndall A; Müller-Ladner U; Denton C; Valentini G; Distler O; Fligelstone K; Tyrrel-Kennedy A; Farge D; Kowal-Bielecka O; van den Hoogen F; Cutolo M; Sampaio-Barros PD; Nash P; Takehara K; Furst DE
Ann Rheum Dis; 2009 Sep; 68(9):1377-80. PubMed ID: 19674983
[TBL] [Abstract][Full Text] [Related]
37. Screening and therapy of pulmonary hypertension in systemic sclerosis.
Bull TM
Curr Opin Rheumatol; 2007 Nov; 19(6):598-603. PubMed ID: 17917541
[TBL] [Abstract][Full Text] [Related]
38. Systemic sclerosis: Recent insights.
Elhai M; Avouac J; Kahan A; Allanore Y
Joint Bone Spine; 2015 May; 82(3):148-53. PubMed ID: 25557659
[TBL] [Abstract][Full Text] [Related]
39. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma.
Lonzetti LS; Joyal F; Raynauld JP; Roussin A; Goulet JR; Rich E; Choquette D; Raymond Y; Senécal JL
Arthritis Rheum; 2001 Mar; 44(3):735-6. PubMed ID: 11263791
[No Abstract] [Full Text] [Related]
40. Adult stem cell treatment of scleroderma.
Tyndall A; Furst DE
Curr Opin Rheumatol; 2007 Nov; 19(6):604-10. PubMed ID: 17917542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
